Stock

Phillips Edison & Company Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

Retrieved on: 
Monday, August 2, 2021
Financial markets, Finance, Stock market, Money, Ticker symbol, NASDAQ, Stock, Phillips Edison & Company, Security

Including the exercise of the over-allotment option, PECO issued a total of 19,550,000 shares of common stock in the offering.

Key Points: 
  • Including the exercise of the over-allotment option, PECO issued a total of 19,550,000 shares of common stock in the offering.
  • PECOs common stock began trading on the Nasdaq Global Select Market on July 15, 2021, under the ticker symbol PECO.
  • BTIG, Capital One Securities, Fifth Third Securities, PNC Capital Markets LLC and Regions Securities LLC acted as co-managers for the offering.
  • Phillips Edison & Company, Inc. (PECO) is one of the nations largest owners and operators of omni-channel grocery-anchored neighborhood shopping centers.

Lancer Capital Completes Tender Offer for Shares of Iconix Brand Group

Retrieved on: 
Monday, August 2, 2021
Corporate finance, Financial economics, Finance, Iconix Brand Group, Iconix, Stock market, Iconix, Stock, Tender offer

NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Iconix Merger Sub Inc. (Purchaser), a subsidiary of Iconix Acquisition LLC (Parent) and an affiliate of Lancer Capital, LLC (Lancer Capital), and Iconix Brand Group Inc. (Iconix) (Nasdaq: ICON) today announced the successful completion of Purchasers offer to purchase all the outstanding shares of Iconix common stock for $3.15 per share, without interest and subject to any applicable withholding taxes, net to the seller in cash.

Key Points: 
  • NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Iconix Merger Sub Inc. (Purchaser), a subsidiary of Iconix Acquisition LLC (Parent) and an affiliate of Lancer Capital, LLC (Lancer Capital), and Iconix Brand Group Inc. (Iconix) (Nasdaq: ICON) today announced the successful completion of Purchasers offer to purchase all the outstanding shares of Iconix common stock for $3.15 per share, without interest and subject to any applicable withholding taxes, net to the seller in cash.
  • Continental Stock Transfer & Trust Company, the depositary and paying agent for the tender offer, has advised Lancer Capital that approximately a total of 8,193,534 shares of common stock of Iconix were validly tendered into and not withdrawn from the tender offer (excluding those shares delivered pursuant to Notices of Guaranteed Delivery), representing approximately 56.3037% of the currently outstanding shares of common stock of Iconix.
  • The number of shares of common stock of Iconix tendered into the tender offer (excluding those shares delivered pursuant to Notices of Guaranteed Delivery) satisfies the minimum tender condition of the tender offer.
  • Iconix and Lancer Capital will take steps to cause the shares of common stock of Iconix to be deregistered under the Exchange Act as promptly as practicable.

Cytek Biosciences Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

Retrieved on: 
Monday, August 2, 2021
Stock market, Financial economics, Finance, Initial public offering, Corporate finance, Money, Stock, Prospectus, Underwriting, Red herring prospectus, Greenshoe

With the addition of the full exercise of the underwriters option to purchase additional shares, the total number of shares sold in this offering increased to 16,749,330, and the aggregate gross proceeds to Cytek, before deducting underwriting discounts and commissions and estimated offering expenses, were $237 million.

Key Points: 
  • With the addition of the full exercise of the underwriters option to purchase additional shares, the total number of shares sold in this offering increased to 16,749,330, and the aggregate gross proceeds to Cytek, before deducting underwriting discounts and commissions and estimated offering expenses, were $237 million.
  • The offering consisted of 13,949,401 shares issued and sold by Cytek, and 2,799,929 shares sold by the selling stockholders named in the prospectus.
  • Cytek did not receive any proceeds from the sale of shares by the selling stockholders.
  • Cytek, Full Spectrum Profiling, FSP and Northern Lights are trademarks or registered trademarks of Cytek Biosciences, Inc.

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Friday, July 30, 2021
Financial markets, Finance, Money, Corporate finance, Stock market, Employee stock ownership, Fundamental analysis, Restricted stock, Stock, Futures contract, NASDAQ, Short

The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).

Key Points: 
  • The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
  • The employees received, in the aggregate, options to purchase 20,450 shares of Sarepta's common stock, and in the aggregate 10,400 restricted stock units (RSUs).
  • Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short.
  • We encourage investors and potential investors to consult our website regularly for important information about us.

BankFinancial Corporation Declares Cash Dividend

Retrieved on: 
Friday, July 30, 2021
Finance, Financial markets, Money, Corporate finance, Equity securities, Dividend, Shareholders, NASDAQ, Common stock, Stock, Bank, ING Group

BURR RIDGE, Ill., July 30, 2021 (GLOBE NEWSWIRE) -- BankFinancial Corporation (Nasdaq BFIN) (BankFinancial) announced that its Board of Directors declared a cash dividend of$0.10 per common share.

Key Points: 
  • BURR RIDGE, Ill., July 30, 2021 (GLOBE NEWSWIRE) -- BankFinancial Corporation (Nasdaq BFIN) (BankFinancial) announced that its Board of Directors declared a cash dividend of$0.10 per common share.
  • The dividend will be payable onAugust 27, 2021, to stockholders of record on August 11, 2021.
  • BankFinancial Corporation is the holding company for BankFinancial, NA, a national bank providing banking, wealth management andfiduciaryservices to individuals, families, and businesses in the Chicago metropolitan area and on a regional or national basis for commercial finance, equipment finance, commercial real estate finance and treasury management business customers.OnJune 30, 2021, BankFinancial had total assets of$1.657 billion, total loans of$1.032 billion, total deposits of$1.439 billion and stockholders equity of$166 million.
  • BankFinancial Corporations common stock trades on the Nasdaq Global Select Market under the symbol BFIN.

Clarus Announces $0.025 Per Share Quarterly Dividend

Retrieved on: 
Friday, July 30, 2021
Financial markets, Finance, Financial economics, Dividend, Shareholders, Equity securities, Stock market, Corporate finance, NASDAQ, Salt Lake City, Stock

SALT LAKE CITY, July 30, 2021 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR) (Clarus and/or the Company), a global company focused on the outdoor and consumer enthusiast markets, announced that its board of directors has confirmed the Companys regular quarterly cash dividend of $0.025 per share.

Key Points: 
  • SALT LAKE CITY, July 30, 2021 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR) (Clarus and/or the Company), a global company focused on the outdoor and consumer enthusiast markets, announced that its board of directors has confirmed the Companys regular quarterly cash dividend of $0.025 per share.
  • The cash dividend will be paid on August 20, 2021, to all stockholders of record as of August 9, 2021.
  • Headquartered in Salt Lake City, Utah, Clarus Corporation is a leading developer, manufacturer and distributor of best-in class outdoor equipment and lifestyle products focused on the climb, ski, mountain, and sport markets.
  • We assume no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release.

Taitron Announces Quarterly Cash Dividend

Retrieved on: 
Friday, July 30, 2021
Finance, Money, Corporate finance, Dividends, Equity securities, Shareholders, Stock market, Common stock, Stock, Ex-dividend date, Dividend yield

LOS ANGELES, July 30, 2021 (GLOBE NEWSWIRE) -- Taitron Components Incorporated (NASDAQ:TAIT) today announced that its Board of Directors has declared a quarterly cash dividend of $0.04 per share of common stock, payable on August 31, 2021 to stockholders of record as of the close of business on August 13, 2021.

Key Points: 
  • LOS ANGELES, July 30, 2021 (GLOBE NEWSWIRE) -- Taitron Components Incorporated (NASDAQ:TAIT) today announced that its Board of Directors has declared a quarterly cash dividend of $0.04 per share of common stock, payable on August 31, 2021 to stockholders of record as of the close of business on August 13, 2021.
  • Under our revised dividend policy, the Company will now target a cash dividend to our stockholders in the amount of $0.16 per share per annum, payable in equal $0.04 per share quarterly installments.
  • Subsequent dividend declarations and the establishment of record and payment dates for such future dividend payments, if any, are subject to the Board of Directors' continuing determination that the dividend policy is in the best interests of the Company's stockholders.
  • The dividend policy may be suspended or cancelled at the discretion of the Board of Directors at any time.

TriState Capital Declares Quarterly Dividends on Perpetual Preferred Stock

Retrieved on: 
Tuesday, August 3, 2021
Banking, Professional services, Finance, Financial markets, Finance, Financial economics, Equity securities, Corporate finance, Stock market, Dividends, Preferred stock, NASDAQ, Stock, Dividend yield, Ex-dividend date

The Board of Directors of TriState Capital Holdings, Inc. (Nasdaq: TSC) declared quarterly dividends on the companys outstanding non-cumulative perpetual preferred stock.

Key Points: 
  • The Board of Directors of TriState Capital Holdings, Inc. (Nasdaq: TSC) declared quarterly dividends on the companys outstanding non-cumulative perpetual preferred stock.
  • A dividend of $0.421875 per depositary share of Series A Non-Cumulative Perpetual Preferred Stock (Nasdaq: TSCAP) is payable on October 1, 2021 to holders of record as of September 15, 2021.
  • A dividend of $0.3984375 per depositary share of Series B Non-Cumulative Perpetual Preferred Stock (Nasdaq: TSCBP) is payable on October 1, 2021 to holders of record as of September 15, 2021.
  • A dividend of 0.01745 shares of Series C Non-Cumulative Perpetual Preferred Stock and cash in the amount of $34,000 is payable on October 1 to the holder of record as of September 15, 2021.

ViacomCBS Declares Quarterly Cash Dividends

Retrieved on: 
Tuesday, August 3, 2021
TV and Radio, General Entertainment, Entertainment, Film & Motion Pictures, Financial markets, Finance, Companies, Corporate finance, Equity securities, Stock market, ViacomCBS, Progressivism in the United States, Viacom, Dividend, Preferred stock, Stock

ViacomCBS Inc. (NASDAQ: VIAC; VIACA) today announced that its Board of Directors has declared a quarterly cash dividend of $0.24 per share on both its Class A and Class B Common Stock.

Key Points: 
  • ViacomCBS Inc. (NASDAQ: VIAC; VIACA) today announced that its Board of Directors has declared a quarterly cash dividend of $0.24 per share on both its Class A and Class B Common Stock.
  • At the same time, the Board of Directors also declared a quarterly cash dividend of $1.4375 per share on its 5.75% Series A Mandatory Convertible Preferred Stock.
  • ViacomCBS (NASDAQ: VIAC; VIACA) is a leading global media and entertainment company that creates premium content and experiences for audiences worldwide.
  • For more information about ViacomCBS, please visit www.viacomcbs.com and follow @ViacomCBS on social platforms.

PharmaCyte Biotech Announces Uplist to The Nasdaq Capital Market and Launch of Public Offering

Retrieved on: 
Monday, August 2, 2021
Oncology, Health, Diabetes, Genetics, Pharmaceutical, Biotechnology, Finance, Financial markets, Financial economics, Stock market, Corporate finance, Initial public offering, OTC Markets Group, Shelf registration, Security, Public offering, NASDAQ, Stock

All of the securities to be sold in the offering are to be offered by PharmaCyte.

Key Points: 
  • All of the securities to be sold in the offering are to be offered by PharmaCyte.
  • The Companys common stock will continue to trade on the OTC Markets quotation system on the OTCQB Venture Market until trading commences on Nasdaq, which the Company expects to occur following the pricing of the proposed public offering.
  • The offering, however, is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
  • The securities described above are being offered by PharmaCyte pursuant to a shelf registration statement on Form S-3 (File No.